Centessa Pharmaceuticals(CNTA.US)

Last Updated 19:00:00 ET
longbridge loading

02:49 ETAre CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?

prnewswire·
US
CNTA
+0.15%
US
WSR
-0.11%
US
GDOT
+0.08%
prnewswire·
US
CNTA
+0.15%
US
WSR
-0.11%
US
GDOT
+0.08%

15:12 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA

prnewswire·
US
CNTA
+0.15%
US
CLBK
-1.11%
US
AFBI
0.00%
prnewswire·
US
CNTA
+0.15%
US
CLBK
-1.11%
US
AFBI
0.00%

Centessa Sets June Vote on $38-Per-Share Eli Lilly Takeover with Added CVR Upside

Tip Ranks·
US
CNTA
+0.15%
US
LLY
+3.37%
US
ARKG
+0.04%
Tip Ranks·
US
CNTA
+0.15%
US
LLY
+3.37%
US
ARKG
+0.04%

Market Chatter: Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions

Fidelity·
US
LLY
+3.37%
US
CNTA
+0.15%
US
ELIL
+5.56%
Fidelity·
US
LLY
+3.37%
US
CNTA
+0.15%
US
ELIL
+5.56%

Centessa Pharmaceuticals | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
CNTA
+0.15%
Earnings Watch·
US
CNTA
+0.15%

16:33 ETAre CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders?

prnewswire·
US
CNTA
+0.15%
US
LLY
+3.37%
US
CWAN
-0.12%
prnewswire·
US
CNTA
+0.15%
US
LLY
+3.37%
US
CWAN
-0.12%

Centessa Pharmaceuticals' (CNTA) Equal Weight Rating Reaffirmed at Wells Fargo & Company

Market Beat·
US
CNTA
+0.15%
Market Beat·
US
CNTA
+0.15%
© 2026 Longbridge｜Disclaimer